- Staat
- OH
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 22.12.2021
- Impfdatum
- 15.12.2021
- Beginn
- 15.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Febrile convulsion
Symptomtext
Febrile Seizure.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Febrile convulsion
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No.
- Vorgeschichte
- Febrile seizures when sick since 07/2018.
- Andere Medikamente
- N/A
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 27.09.2021
- Impfdatum
- 26.08.2021
- Beginn
- 27.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bell's palsy
Borrelia test negative
SARS-CoV-2 test negative
White blood cell count normal
Symptomtext
Bells Palsy (Left side of face); First appeared day following the vaccine; Remains ongoing, awaiting neurology consult.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bell's palsy
- Hospital-Tage
- -
- Labordaten
- Labs completed to include lymes and covid. All test were negative. All lab values including WBCs were within normal range.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 19.08.2022
- Impfdatum
- 18.08.2022
- Beginn
- 18.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Body temperature increased
Chest X-ray normal
Dyspnoea
Enterovirus test positive
Human rhinovirus test positive
Symptomtext
Patient presented to ED about 5 hours after vaccine with shortness of breath and temperature 100.4
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- CXR normal, nasal swab positive for rhinovirus/enterovirus
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- congenital atrial septal defect
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 15.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dyspnoea
Eye pruritus
Injection site erythema
Injection site swelling
Lip swelling
Ocular hyperaemia
Productive cough
Respiratory symptom
Rhinorrhoea
Urticaria
Wheezing
Symptomtext
Patient experienced localized swelling and erythema that spread predominantly from the right thigh injection site. Patient had increased work of breathing, developed wheezing, and began having a productive cough, runny nose, and red/itchy eyes. Hives appeared on the left side of the neck, left shoulder, and left arm. Lips were swollen. This began within seconds of receiving the vaccine. Patient was given EpiPen Jr (0.15mg) x 1 immediately, 2 puffs of albuterol and 22.25 mg of Benadryl at 1510. Respiratory symptoms, runny nose, and cough improved following EpiPen administration. Patient was transferred to ED for further monitoring. Patient did not receive additional medication while admitted to the ED.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None that the provider was made aware of.
- Vorgeschichte
- Congenital clinodactyly Hypoplasia of both thumbs Prematurity Duodenal atresia VSD (spontaneous closure) PDA (spontaneous closure( L lower pulmonary vein stenosis
- Andere Medikamente
- Ibuprofen and Tylenol listed on patient's medication list at time of visit.
- Allergien
- Chlorhexidine, burns patients skin
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 03.04.2023
- Impfdatum
- 31.03.2023
- Beginn
- 31.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Pruritus
Pyrexia
Swelling
Symptomtext
Dad states that patient started running 104 fever the night shots were given. Dad not sure how long fever lasted due to sleeping. Itching, pain, swelling started the next morning. Dad notes swelling has continued to get worse and area grow larger. Dad states he gave her ibuprofen one time. Fever resolved. Swelling and pain continued as of today (4/3/23).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- None.
- Andere Medikamente
- None.
- Allergien
- None known.
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 09.12.2022
- Impfdatum
- 21.10.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Urticaria
Symptomtext
Pt. had redness around the nape of her neck and her ears earlier the morning following the vaccinations. No other symptoms at that time, 6 hours later I have noticed hives. A few on her neck and some on her lower back. I gave her Benadryl at 8:30 Friday ( day after vaccine) night and she was rash free the next morning but then around 3:30pm it came back and it was odd because it was red almost opposite of where it was red the day before. It appeared to me to look like a chemical burn from the inside out. I would like to share photos if able.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 24.08.2022
- Impfdatum
- 17.08.2022
- Beginn
- 20.08.2022
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Arthralgia
Epididymitis
Pain in extremity
Testicular disorder
Testicular pain
Ultrasound scan
Urine analysis
Symptomtext
Had his immunizations on 8/17, and then on 8/20 woke up and had some right testicular discomfort. The pain worsened and they brought him into the ER and he was diagnosed with epididymitis. No evidence of UTI so treated conservatively and he is doing better now. I do not know if this is a side effect of the vaccine or unrelated. Also reports some leg pain and knee pain but it is migratory and bilateral and not affecting him playing. The DTaP IPV was his first dose of Kinrix, but he has had 4 previous doses of DTaP and 3 previous doses of IPV. We did an MMR V ProQuad combo and this is the first time he received the combination, previously had MMR and varicella separately.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- Ultrasound 8/20, U/A 8/20
- Aktuelle Erkrankungen
- about 1 month prior to event, family dog scratched patient's face, no infection or abx
- Vorgeschichte
- asthma
- Andere Medikamente
- Triamcinolone cream prn, albuterol inhaler prn, Claritin
- Allergien
- NKDA, NKA
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 10.08.2022
- Impfdatum
- 08.08.2022
- Beginn
- 09.08.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site swelling
Pain in extremity
Symptomtext
Reports child woke up the morning after receiving the shots with swelling noted to right upper arm, shoulder and upper back on the right side down to the elbow. Mother reports the swelling worsened during the day. Mother further reports that the child is continuing to use his arm and fingers as normal. Child reports that arm is hurting. Child was taken to the emergency room last night. Child waited 6 hours, family left without being seen due to large number of patients waiting to be seen. Ice pack was applied, child went to sleep. Mother reports that swelling to the right arm is unchanged today. States child is participating in normal activities today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Mother states child has not been ill for 1 month prior to date of vaccination
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- Mother denies any allergies
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 27.07.2022
- Impfdatum
- 25.07.2022
- Beginn
- 25.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pain
Injection site swelling
Symptomtext
erythema and swelling of right upper extremity with mild pain without functional impairment or systemic symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 20.07.2022
- Beginn
- 20.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature increased
Injection site erythema
Injection site swelling
Symptomtext
Patients mother complains of swollen reddened area from both injection sites and a temperature of 100.8 Fahrenheit persistent over 48 hours.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Mother said she was taking Ibuprofen
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 11.07.2022
- Impfdatum
- 08.07.2022
- Beginn
- 11.07.2022
- Tage bis Beginn
- 3,0
- Dosis
- 5
- Route/Site
- ID / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site reaction
Pain
Peripheral swelling
Pruritus
Symptomtext
Pt came in the clinic today 07/11/2022 with right leg swelling, pain, itchiness, and redness. Pt also had a mark from the injection site that was in the middle of the outside of the thigh (between the fatty tissue and the vastus lateralis.) Pt was given a dose of Diphenhydramine HCI (25 mg). Pt mom stated site got worse and spread. Pt was instructed and prescribed cephALEXin (KEFLEX) 250 mg/5 mL suspension.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No other illnesses are listed in pt chart at the time of vaccination and up to one month prior.
- Vorgeschichte
- Pts problem list includes Tinea corporis, Redness of eye, and Preauricular sinus, right.
- Andere Medikamente
- None at the time of vaccination.
- Allergien
- No known allergies to medications, foods, or other products.
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 03.06.2022
- Impfdatum
- 01.06.2022
- Beginn
- 01.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Infant irritability
Injection site irritation
Product administered to patient of inappropriate age
Symptomtext
Pt was given Kinrix at 4 months of age. This is only licensed for 4 -6 year olds. Pt had no immediate reactions. Pt was called two days later and mother reports some small amount of irritation on the thigh and some irritability. Over all no significant adverse effects noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site irritation
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 11.05.2022
- Impfdatum
- 09.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site pain
Nodule
Skin warm
Symptomtext
per mother pt has a 4 inch knot with redness, hot to touch and site tenderness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 29.04.2022
- Impfdatum
- 26.04.2022
- Beginn
- 28.04.2022
- Tage bis Beginn
- 2,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypersensitivity
Immunisation reaction
Injection site discomfort
Injection site erythema
Injection site induration
Injection site pain
Injection site swelling
Injection site warmth
Symptomtext
Per Dr visit/note: This is a little interesting that it is 3 days out from his vaccination initially and he had not had any issues prior to this morning. I wonder if this is a type IV delayed hypersensitivity reaction. After discussing with my nurse who gives lots of childhood immunizations, this likely was the Kinrix vaccine given IM in the left anterior thigh. There is no evidence of acute infection at this time other than the erythema and the warmth but there is no fluctuance. My suspicion is that the most likely diagnosis is hypersensitivity reaction although infection is not entirely ruled out. He has no systemic symptoms at all at this time, no fevers or chills. He is moving the joint above and below this area fine without any issues and there is no lymphangitic streaking. I do not see an indication for blood work at this time today but if this progresses, there is lymphangitis type symptoms or he seems to be progressing I of course would recommend immediate return for further evaluation. For now I recommend antihistamine, ice and compression to see if this will help reduce some of the response that he is having. I want this rechecked in 24 to 48 hours as well. Mom was comfortable with this plan. Patient is brought in by his mother today for evaluation of significant swelling and erythema noted in an injection site from his 4-year-old vaccines. He received his vaccines on Monday 4/26. Mom did not notice any immediate reaction. He complained slightly that day of some discomfort and pain in his left leg but it was not anything that was limiting his activity. Mom gave him a shower last night and did not notice any redness or swelling that was apparent. When he got picked up from preschool this morning he told his mom that his leg hurt and so she pulled down his pants to look at his leg and noticed that it was substantially erythematous, firm to the touch, warm and she was very concerned of possible infection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discomfort
- Hospital-Tage
- -
- Labordaten
- No testing or lab results
- Aktuelle Erkrankungen
- Hematemisis in pediatric patient (4/14/22) Gastroenteritis (February, 2022)
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 21.04.2022
- Impfdatum
- 29.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Irritability
Pyrexia
Symptomtext
Fever and fussines developed after receiving vaccines Tmax of 101, higher than expected for normal immune response to vaccines No s/s of infection or other illness Continue ibuprofen, may add APAP as needed when ibuprofen wears off prior to 6 hours Push fluids to prevent dehydration F/u tomorrow if not significantly improved
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 06.04.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site induration
Injection site warmth
Rash
Symptomtext
There is redness warmth and induration from her left mild deltoid area o almost the elbow. Kinrix and Varicella were given on L deltoid. Benadryl and Ibuprofen given in clinic. Rash showed some improvement with Benadryl and Ibuprofen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- Complex Febrile Convulsions
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 25.03.2022
- Impfdatum
- 24.03.2022
- Beginn
- 24.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Flushing
Lip swelling
Pruritus
Pyrexia
Symptomtext
0855 Dtap-IPV and MMR administered 0900 Mom reports child is itching the neck. Child taken to pediatric clinic accompanied by the nurse to Doctor 0902 Examined by Doctor. Benadryl 25mg given orally Was sent home around 0930 Per mother on the way home child developed facial flushing, and lip swelling and feeling of fever and taken to Hospital Discharged home on 03/24/2022 on oral prednisone for 4 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- 03 March 2022 Bilateral impacted cerumen - was referred to ENT
- Vorgeschichte
- Autism, Hydrocephalus
- Andere Medikamente
- EPIPEN JR. prn TYLENOL prn
- Allergien
- Gelatin- Swelling
- Vorherige Impfungen
- varicella at age 1 year
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 18.03.2022
- Impfdatum
- 18.03.2022
- Beginn
- 18.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Urticaria
Symptomtext
thirty minutes after administration of series of vaccines patient broke out in mild hives. Benadryl 25mg PO liquid given. Rash then subsided within 45 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 18.02.2022
- Impfdatum
- 09.02.2022
- Beginn
- 10.02.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pain in extremity
Peripheral swelling
Symptomtext
Swollen painful thigh which was noticed the following evening and worsened, which looked like a cellulitis.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Possible seasonal allergies
- Andere Medikamente
- none
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 03.02.2022
- Tage bis Beginn
- 2,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Chorea
Injection site rash
Symptomtext
Patient with Juta chorea like rash, centralized around injection site
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Factor VII deficiency
- Vorgeschichte
- Factor VII deficiency
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 15.01.2022
- Impfdatum
- 01.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 12,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Injection site swelling
Symptomtext
Patient developed itching, redness, and swelling in both legs at the site of the injections within 24 hours after administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 24.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 24.11.2021
- Tage bis Beginn
- 2,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site induration
Injection site warmth
Symptomtext
Mother reports quarter-sized hard, red area on back of right arm that is hot to the touch. Child is not complaining about site and is acting normally. Mother declined to see PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 30.08.2021
- Beginn
- 30.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Confusional state
Injection site swelling
Injection site urticaria
Pyrexia
Vomiting
Symptomtext
Child vomited, developed a fever, confusion, hives, and swelling at the injection site of the leg that Kinrix was given in.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- -
- Andere Medikamente
- MTV; Probiotic; Hydroxyzine; Ceterezine
- Allergien
- Bananas; wheat; milk
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 30.06.2023
- Impfdatum
- 02.06.2023
- Beginn
- 02.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Patient received a vaccine Kinrix and it was expired 5/7/23
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 1,3
- Geschlecht
- M
- Eingang
- 07.06.2023
- Impfdatum
- 06.06.2023
- Beginn
- 06.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine given was expired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 05.06.2023
- Impfdatum
- 02.06.2023
- Beginn
- 02.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
received an expired dose of Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. On 02-JUN-2023, the patient received Kinrix. On 02-JUN-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: received an expired dose of Kinrix). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-JUN-2023 The reporter consented to follow up via email. The patient received an expired dose of Kinrix, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 23.05.2023
- Impfdatum
- 18.05.2023
- Beginn
- 18.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product administered to patient of inappropriate age
Symptomtext
Wrong age; expired dose of Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 9-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2n, expiry date 07-MAY-2023) for prophylaxis. On 18-MAY-2023, the patient received the 3rd dose of Kinrix. On 18-MAY-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Wrong age) and expired vaccine used (Verbatim: expired dose of Kinrix). The outcome of the inappropriate age at vaccine administration and expired vaccine used were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date:18-MAY-2023 A medical assistant called in to report that a 9 month old patient was given an expired dose of Kinrix and wished to know how to proceed. Information about the vaccine, patient and event were recorded. The corresponding medical information was read. The Vaccine Administration Facility is the same as Primary Reporter", The reporter consented to follow up. The 9 months old patient was administered with expired vaccine which led to Expired vaccine used and Inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 22.05.2023
- Impfdatum
- 07.05.2023
- Beginn
- 07.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
16 month old male received a dose of Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. On 07-MAY-2023, the patient received Kinrix. On 07-MAY-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 16 month old male received a dose of Kinrix). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 17-May-2023 The reporter reported that the 16 month old child patient received Kinrix vaccine. The reporter stated that the patient did not experienced any symptoms. The vaccine administration facility was the same as primary reporter. The reporter did consent to follow up via email. The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 19.05.2023
- Impfdatum
- 15.05.2023
- Beginn
- 15.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired dose administered.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. On 15-MAY-2023, the patient received Kinrix. On 15-MAY-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered.). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 15-MAY-2023 Nurse called to inform that a patient accidentally received a dose of Kinrix that had already expired back in 7th May 2023. The Vaccine Administration Facility was the same as primary reporter. The reporter did consent to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 19.05.2023
- Impfdatum
- 09.05.2023
- Beginn
- 09.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Inappropriate schedule of product administration
Symptomtext
Expired dose administered; This was the patient's fourth DTaP and IPV dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired product administered in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. On 09-MAY-2023, the patient received the 4th dose of Kinrix. On 09-MAY-2023, an unknown time after receiving Kinrix, the patient experienced expired product administered (Verbatim: Expired dose administered) and inappropriate schedule of vaccine administered (Verbatim: This was the patient's fourth DTaP and IPV dose). The outcome of the expired product administered and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 09-May-2023 The nurse reported that the patient received a dose of Kinrix, which had an expiration date of 07 May 2023. This was the patient's fourth DTaP and IPV dose. At the time of reporting, the dose had not been repeated. The reporter consented to follow up. The vaccine administration facility was the same as primary reporter. The patient was administered an expired fourth dose of Kinrix, which led to expired vaccine used and this was the patient's fourth DTaP and IPV dose which led to inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 18.05.2023
- Impfdatum
- 18.05.2023
- Beginn
- 18.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
No reaction. Patient was administered a vaccine that is expired the vaccine was given on 5/18/2023 and expired on 5/7/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 17.05.2023
- Impfdatum
- 08.05.2023
- Beginn
- 08.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
dose of expired Kinrix was administered to the patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. On 08-MAY-2023, the patient received Kinrix. On 08-MAY-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: dose of expired Kinrix was administered to the patient). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-MAY-2023 The reporter was a Medical Assistant. The reporter consented to contact. An expired Kinrix was administered to the patient, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 04.05.2023
- Impfdatum
- 13.12.2021
- Beginn
- 14.12.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Adverse event
Immunisation reaction
Symptomtext
Adverse effect of other vaccines and biological substances, initial encounter on 2021-12-14.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Other iron deficiency anemias; Allergic rhinitis due to animal (cat) (dog) hair and dander; Atopic dermatitis, unspecified; Prurigo NOS; Acne vulgaris; Elevated blood-pressure reading, without diagnosis of hypertension; Need for immunization against single bacterial diseases; Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age; Other specified personal risk factors, not elsewhere classified
- Vorgeschichte
- -
- Andere Medikamente
- CETIRIZINE HCL 1 MG/ML ORAL SOLN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 0,6
- Geschlecht
- F
- Eingang
- 27.04.2023
- Impfdatum
- 12.10.2022
- Beginn
- 12.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient was administered Kinrix vaccine at 7mths, when it should only be administered for children 4-6 years old. Patient had no adverse reaction. Patient was referred to administering facility for just this one vaccination, then returned back to PCP. PCP and patient's mother are both aware.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 04.04.2023
- Impfdatum
- 17.01.2023
- Beginn
- 17.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Patient of inappropriate age got Kinrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. Concomitant products included PEDIARIX. On 17-JAN-2023, the patient received Kinrix. On 17-JAN-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Patient of inappropriate age got Kinrix). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-Mar-2023 The vaccine administration facility was the same as primary reporter. The reporter shared with 2nd line agent that a dose of Pediarix was administered. The reporter consented to follow-up. The patient received a dose of Kinrix at an inappropriate age, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PEDIARIX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- F
- Eingang
- 01.04.2023
- Impfdatum
- 20.03.2023
- Beginn
- 20.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
Kinrix given to a 12-month-old; Kinrix as third dose of DTaP and IPV; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. Previously administered products included Vaxelis (first dose of DTaP and IPV as Vaxelis received on 29 December 2022) and Pediarix (second dose received on 30 January 2023). On 20-MAR-2023, the patient received the 1st dose of Kinrix. On 20-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Kinrix given to a 12-month-old) and inappropriate schedule of vaccine administered (Verbatim: Kinrix as third dose of DTaP and IPV). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 20-Mar-2023 and 21-Mar-2023 The nurse manager called back to report that patient received their first dose of DTaP and IPV as Vaxelis on 29 December 2022 and second dose of each as Pediarix on 30 January 2023. The nurse called to report that a 12-month old patient accidentally received 3rd dose of Kinrix and wished to know how to proceed. Kinrix was the patient's third dose of DTaP and IPV.The reporter consented to follow up. Information about the vaccine and patient were provided. The vaccine administration facility was the same as primary reporter. The 12-month old patient accidentally received 3rd dose of Kinrix, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- -
- Geschlecht
- M
- Eingang
- 31.03.2023
- Impfdatum
- 16.02.2023
- Beginn
- 16.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
7 YO patient was administered Kinrix; Was supposed to receive IPOL and "something else"; Already received 5 of DTaP and 4 of IPV; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis. Previously administered products included DTaP (received 5 doses of DTaP) and IPV (4 years child received 4 doses of IPV). On 16-FEB-2023, the patient received Kinrix. On 16-FEB-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 7 YO patient was administered Kinrix), wrong vaccine administered (Verbatim: Was supposed to receive IPOL and "something else") and inappropriate schedule of vaccine administered (Verbatim: Already received 5 of DTaP and 4 of IPV). The outcome of the inappropriate age at vaccine administration, wrong vaccine administered and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 16-Mar-2023 The nurse reported that the 7 year old patient was administered a dose of Kinrix. The nurse believes the patient was supposed to have received IPOL and something else but she was not sure. The nurse reported that prior to the Kinrix dose, the patient had already received 5 doses of DTaP and 4 doses of IPV, however the fourth dose of IPV was given before the child was 4 years of age. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter. The 7 year old patient was administered a dose of Kinrix, which led to age at vaccine administration, wrong vaccine administered, inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 28.03.2023
- Impfdatum
- 13.03.2023
- Beginn
- 13.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
4 month old received Kinrix; Supposed to be 2nd dose of DTap; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N) for prophylaxis. On 13-MAR-2023, the patient received Kinrix. On 13-MAR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 4 month old received Kinrix) and inappropriate schedule of vaccine administered (Verbatim: Supposed to be 2nd dose of DTap). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 13-Mar-2023 On 13th March 2023 a Medical Assistant informed that a 4-month old patient had received a dose of Kinrix that was supposed to be the 2nd dose of the DTap series. The Vaccine Administration Facility is the same as Primary Reporter. The reporter consented to follow up. The 4-month-old patient received Kinrix as 2nd dose of DTap, which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- M
- Eingang
- 02.03.2023
- Impfdatum
- 24.02.2023
- Beginn
- 24.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
inadvertently given Kinrix instead of Infanrix; 18 MO received Kinrix; This case was reported by a other health professional via sales rep and described the occurrence of wrong vaccine administered in a 18-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date unknown) for prophylaxis. On 24th February 2023, the patient received Kinrix. On 24th February 2023, unknown after receiving Kinrix, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. Additional Information: GSK receipt date: 24-FEB-2023 Reporter's comment: The patient was inadvertently given Kinrix instead of Infanrix. The reporter needs to know what needs to be done to make sure there was no harm and also that he was covered. The reporter agrees to follow up from GlaxoSmithKline. Additional Supportive Information: The patient received Kinrix instead of Infanrix, which led to wrong vaccine administered. 13 months old patient received Kinrix vaccine, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,5
- Geschlecht
- M
- Eingang
- 20.02.2023
- Impfdatum
- 10.02.2023
- Beginn
- 10.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Kinrix administered to a 6 months-old; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th February 2023, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 10th February 2023, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-FEB-2023 Reporter's Comments: The reporter consented to follow-up. Additional Supportive Information: The patient was administered Kinrix vaccine at inappropriate age, which led inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 13.02.2023
- Impfdatum
- 27.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
There were NO adverse events or reactions. Kinrix was given when last DTap was Pentavalent therefore. Kinrix should not have been given. Per discussion with doctor, Kinrix administration was acceptable. All 7 previous dose of Polio were oral and given after 2016, so therefore did not count.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- NONE
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 2,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 23.01.2023
- Beginn
- 23.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse effects were noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 16.12.2022
- Impfdatum
- 08.06.2022
- Beginn
- 08.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
13 month old received Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 8th June 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 8th June 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 7-Dec-2022 Reporter's comment: The reporter consented to follow-up. The case was for 2 of 5 linked patients reported by same reporter. Additional supportive information: The patient received a dose of Kinrix at inappropriate age, which led to inappropriate age at vaccine administration.; Sender's Comments: US-GSK-US2022183610:Same reporter US-GSK-US2022183611:Same reporter US-GSK-US2022183612:Same reporter US-GSK-US2022183615:Same reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 15.12.2022
- Impfdatum
- 17.10.2022
- Beginn
- 17.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
Child was given Kinrix, but should have received Tdap. No adverse reaction noted. Will need to receive Tdap at age 10-12 years old.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 13.12.2022
- Impfdatum
- 26.01.2022
- Beginn
- 26.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Vaccination error
Symptomtext
On 1/26/2022 and 3/29/22 client was given a lesser dose of immunization. While doing an imms clinic found a vaccine error x2 on the same client. Gave vaccines to this client at her 2 month and 4-month shots. A dose of Kinrix was administered at both visits and Kinrix is only authorized for children ages 4-6 years.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 1,6
- Geschlecht
- F
- Eingang
- 30.11.2022
- Impfdatum
- 25.10.2022
- Beginn
- 25.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
The patient had a provider order for Dtap and received Kinrix
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 21.11.2022
- Impfdatum
- 14.11.2022
- Beginn
- 14.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Extra dose of varicella immunization was given to patient. Primary care provider was notified.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- albuterol, pulmicort and claritin.
- Allergien
- No allergies
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,3
- Geschlecht
- M
- Eingang
- 08.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Interchange of vaccine products
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient received 1 dose of Pediarix and followed by 2 doses of Pentacel; 16 month old administered Kinrix; Kinrix by mistake as a 4th dose of DTaP; Kinrix given by mistake instead of Pentacel; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 16-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis, dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis and PENTACEL for prophylaxis. On 28th October 2022, the patient received the 4th dose of Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, the patient received the 1st dose of Pediarix, Pediarix Pre-Filled Syringe Device and the 2nd dose of PENTACEL. On 28th October 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device and not applicable after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration, inappropriate schedule of vaccine administered and wrong vaccine administered. On an unknown date, the patient experienced interchange of vaccine products. On an unknown date, the outcome of the inappropriate age at vaccine administration, inappropriate schedule of vaccine administered, wrong vaccine administered and interchange of vaccine products were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's Comment: The reporter was a medical assistant. The reporter reported that the patient received Kinrix vaccine by mistakenly at the age of 16 months who was supposed to received Pentacel. The reporter stated that the Kinrix vaccine was given as 4th dose of DTaP and IPV schedule. The reporter reported that the patient received 1st dose of Pediarix vaccine and the 2nd and 3rd dose of Pentacel vaccine before the Kinrix vaccine. The reporter did not consent to follow up. Additional supportive information: The patient received Kinirix who was younger than the indicated age which led to inappropriate age at vaccine administration. The patient received Kinirix received as 4th dose of DTap Series which led to Inappropriate schedule of vaccine administered. The patient was administered with Pentacel vaccine after Pediarix , which led to interchange of vaccine products. The reporter reported that, they were intending to administered Pentacel and inadvertently administered Kinrix instead of Pentacel, which led to wrong vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 20.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
15 month patient received Kinrix; Kinrix administered instead of infanrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 20th October 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 20th October 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-OCT-2022 Reporter's Comment: This case was reported by nurse. Nurse reported that 15 month patient received Kinrix. Nurse was not sure if patient received 3 doses of Pediarix before or just 2. Nurse thought the correct vaccine that should had being administered instead of Kinrix was Infanrix. Reporter did not consent to follow up. Additional supportive information: As patient received vaccine at inappropriate age and received Kinrix instead of Pediarix which led to inappropriate age at vaccination and wrong vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 17.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Patient was given Dtap/Polio ( Kinrix). Patient is age 14. Patient should have received Tdap
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 06.09.2022
- Impfdatum
- 07.04.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- 116,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Vaccination given too early.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 06.09.2022
- Impfdatum
- 19.11.2021
- Beginn
- 19.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N?A
- Andere Medikamente
- No Adverse reaction
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- WV
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 30.08.2022
- Impfdatum
- 23.08.2022
- Beginn
- 23.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Kinrix extra dose/Patient already had 5 Dtap, last one Kinrix; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. Previously administered products included Kinrix (1st dose received on 1st December 2021) and Dtap vaccine (received 4 doses on an unknown date). On 23rd August 2022, the patient received the 2nd dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 23rd August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-AUG-2022 Reporter's Comments: The nurse reported that patient received a dose ofKinrix as extra dose by error. Patient already had 5 Dtap vaccines where the last one was a Kinrix vaccine. The reporter consented to follow up. Additional Supportive Information: The patient received by error a Kinrix extra dose which led to extra dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 0,4
- Geschlecht
- F
- Eingang
- 27.08.2022
- Impfdatum
- 06.04.2022
- Beginn
- 06.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
6 month old was vaccinated with Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 5-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th April 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 6th April 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 18-Aug-2022 Reporter's Comments: The nurse reported that the 6 months old patient was vaccinated with Kinrix. The reporter consented to follow up. Additional Supportive Information: The patient received a dose of Kinrix at inappropriate age, which led to inappropriate age at vaccine administration. As per reported information, 6 months old patient received Kinrix but in system it was auto calculated as 5 months therefore auto calculated one was captured in structured field.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 8,0
- Geschlecht
- F
- Eingang
- 19.08.2022
- Impfdatum
- 19.08.2022
- Beginn
- 19.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Patient was administered DTaP/IPV combination in place of a separate TDaP and IPV.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None reported.
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- None reported
- Allergien
- None reported
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 24.07.2022
- Beginn
- 24.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Irritability
Wrong product administered
Symptomtext
Pt was given KINRIX vaccine instead of PEDIARIX vaccine. Dr. contacted parent. Parent states that pt is a little "fussy" otherwise doing ok. No known reactions noted
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Irritability
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- No medications
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 28.07.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
4 month old received the Kinrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 25-Jul-2022 Reporter's comment: The health care professional reported that a 4 month old patient received the Kinrix. The patient was due for their 2nd dose of Dtap and IPV. The Vaccine Administration Facility was the same as Primary Reporter. No reactions were reported. The reporter consented to follow up via email. Additional supportive information: The patient received a dose of Kinrix at inappropriate age, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 21.07.2022
- Impfdatum
- 13.07.2022
- Beginn
- 13.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vaccination error
Symptomtext
Vaccine admin error non-viable vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination error
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- NKDA
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 21.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Poor quality product administered
Symptomtext
Vaccine administration error. Non- viable vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Poor quality product administered
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- NA
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 9,0
- Geschlecht
- F
- Eingang
- 22.06.2022
- Impfdatum
- 29.12.2021
- Beginn
- 29.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Product administration error
Wrong product administered
Symptomtext
Administration error: Kinrix combo vaccine inadvertently given to a 9 year old and age outside of the recommended age group to receive Kindrix/ DTaP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Unknown
- Andere Medikamente
- Unknown
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 17.06.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
child received DTap-IPV instead of DTaP in error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 07.06.2022
- Impfdatum
- 03.06.2022
- Beginn
- 04.06.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Skin warm
Swelling
Symptomtext
The patient received the vaccines on 6/3/22 around 1PM; parents reported about 24 hours later, his right thigh began to turn red and warm with swelling. He was seen in PCP office 6/6/22 with similar symptoms. Patient denied pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 26.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Patient of 1 YO received Kinrix; received Kinrix instead of receiving DTAP and IPV separately; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number 24t2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:18-May-2022 Reporter's comments: Nurse practitioner reported that few months ago the patient of 1year age received Kinrix instead of receiving DTAP and IPV separately. The consent to follow up was given. Additional Supportive Information: The 1 year old patient received Kinrix instead of receiving DTAP and IPV separately, which led to inappropriate age at vaccine administration and wrong vaccine administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
reported a kinrix maladministration, as an 18 months old male patient/Kinrix out of indication; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 18-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-MAY-2022 Reporter's comment: A nurse reported a Kinrix maladministration, as an 18 months old patient received a dose by mistake. The reporter consented to follow up. Additional supportive information: The patient of 18 months old received a dose of Kinrix by mistake, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 19.05.2022
- Impfdatum
- 12.05.2022
- Beginn
- 12.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
Patient was vaccinated with a non-viable vaccine after a temperature excursion under freezing. The excursion was not identified until after the clinic. We have not received any notification of adverse reactions.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VT
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 17.05.2022
- Beginn
- 17.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 5
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Pt. was given a Kinrix vaccine instead of an MMRV.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Developmental and speech delay
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 0,4
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 29.04.2022
- Beginn
- 29.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Kinrix vaccine administered outside of age range. No adverse effects noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 0,7
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 21.04.2022
- Beginn
- 21.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Administered Kinrix to a 8 month old; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 21st April 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 21st April 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-May-2022 Reporter's comments: Clinical Assistant inquired about any information available about the administered dose was okay. They inadvertently administered Kinrix to a 8 month old patient. The reporter did not consent to follow-up. Additional Supportive Information: The patient received Kinrix dose inadvertently, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,4
- Geschlecht
- M
- Eingang
- 25.04.2022
- Impfdatum
- 17.12.2021
- Beginn
- 25.04.2022
- Tage bis Beginn
- 129,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Vaccine was given to a patient under the age of 3. Contacted patient no reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 10.04.2022
- Impfdatum
- 06.04.2022
- Beginn
- 07.04.2022
- Tage bis Beginn
- 1,0
- Dosis
- 5
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cellulitis
Erythema
Oedema
Skin warm
Tenderness
Symptomtext
Localized 6.5cm x 7.5cm area of cellulitis (erythema, edema, warmth, and tenderness to palpation) diagnosed 3 days after the immunization. Treated with PO clindamycin.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cellulitis
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None reported by parent
- Vorgeschichte
- None reported by parent
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 08.04.2022
- Impfdatum
- 18.03.2022
- Beginn
- 01.04.2022
- Tage bis Beginn
- 14,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
On 3/18/22, patient presented to office for immunization update. DTaP and Polio vaccines both due verified by provider and MA. Kinrix was administered. Provider was unaware that Kinrix is invalid if administered as the initial dose of DTaP and Polio. Patient had not received any immunizations prior to age 4 years of age, Thus, Kinrix is invalid and child will need further immunization prior to being up-to-date for school this fall. I have called mother and explained the situation to her and she verbalizes understanding. She is appreciative of the call and agreeable to the plan to have patient return for immunization update (he is scheduled to return on 4/22/22 for this already, as he did not receive his infant/toddler vaccinations required for school and is due for several vaccines). Mother will bring patient to the office for immunization update as planned. There was no adverse event, no harm to patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- innocent heart murmur
- Andere Medikamente
- None
- Allergien
- NKDA; no food allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 29.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
vaccine given to an in appropriate age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 17.02.2022
- Beginn
- 17.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect product formulation administered
Symptomtext
COVID vaccine not diluted before administration
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- iodine
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 3,0
- Dosis
- 5
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Induration
Symptomtext
L upper arm red pink diffuse area 5cm x5cm with upper central induration soft 2cm not flluctuatnt, deprsible , not tender, no secretion
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 09.02.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
her age did not fit with the Vaccine Schedule/Kinrix maladministration; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 1st February 2022, the patient received the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 1st February 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: Nurse reported that a patient received her first Kinrix dose by error as her age did not fit with the vaccine schedule, which led to inappropriate age at vaccine administration. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Vaccine not licensed for this age group
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 27.01.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Vaccine was not licensed for this age group
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 08.01.2022
- Impfdatum
- 03.01.2022
- Beginn
- 03.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
23 month old patient got a dose of Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 23-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 3rd January 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 3rd January 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: A nurse reported that a 23 month old male patient accidentally received a dose of Kinrix, which led to inappropriate age at vaccine administration. No symptoms were reported. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 0,3
- Geschlecht
- M
- Eingang
- 30.12.2021
- Impfdatum
- 23.12.2021
- Beginn
- 23.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 23rd December 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 23rd December 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The nurse reported that a 4 month old patient inadvertently received a dose of Kinrix which led to inappropriate age at vaccine administration. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 22.12.2021
- Impfdatum
- 20.12.2021
- Beginn
- 20.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
pt was overdue for vaccination of DTAP and IPV at age 3 yrs and 8 months, pt was administered 1 dose of kinrix pre-filled syringe intramuscular injection to left thigh on 12/20/21 at approx. 1600 hrs to meet this requirement, no adverse effects reported at time of administration or to the time of this report
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Ibuprofen PRN
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 01.12.2021
- Impfdatum
- 01.12.2021
- Beginn
- 01.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
MMRV given instead of MMR. Patient also received a dose of Varicella
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 29.11.2021
- Impfdatum
- 29.11.2021
- Beginn
- 29.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
RN gave client Kinrix Vaccine because DTAP and IPV were due for 6 month vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 17.11.2021
- Impfdatum
- 07.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Newly hired Medical Assistant mistakenly interpret physician orders and incorrectly administered Kinrix (DTap & IPV combo) vaccine. She believed she was saving the patient from receiving multiple vaccine shots. No treatment needed and no adverse effect was reported by parent
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- None
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 15.11.2021
- Impfdatum
- 27.10.2021
- Beginn
- 27.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Vaccine administered over age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 29.10.2021
- Impfdatum
- 13.09.2021
- Beginn
- 15.09.2021
- Tage bis Beginn
- 2,0
- Dosis
- 4
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Gaze palsy
Symptomtext
1 day after vaccines - started having eyes deviation up and to the right randomly (sometimes to the left) but occurring often. She does wear glasses. She was referred to optho & neurology
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Gaze palsy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 8,0
- Geschlecht
- M
- Eingang
- 28.10.2021
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Client was inadvertently given an unneeded/additional dose of Hep A. 2 dose series was already complete, and he received a 3rd dose. Client also received Kinrix (DTaP-IPV) over age range. Client's mother reported no symptoms following vaccination other than sore arm the following day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- unknown
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 0,2
- Geschlecht
- M
- Eingang
- 22.10.2021
- Impfdatum
- 12.10.2021
- Beginn
- 12.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
Kinrix administered to a two month old; ordered Kinrix instead of Pediarix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 12th October 2021, the patient received the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 12th October 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter inadvertently ordered Kinrix instead of Pediarix and it was administered to a two month old patient, which led to inappropriate age at vaccine administration and wrong vaccine administered. The patient was fine. The reporter consented to follow up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 0,1
- Geschlecht
- M
- Eingang
- 21.09.2021
- Impfdatum
- 10.09.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
2 months old child received the vaccine; This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 2-month-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 10th September 2021, the patient received the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received dose of Kinrix in the left deltoid. The health care professional reported that, 2 months old patient received dose of Kinrix, which led to inappropriate age at vaccine administration. The reporter consented to follow up by phone.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,3
- Geschlecht
- F
- Eingang
- 16.09.2021
- Impfdatum
- 19.08.2021
- Beginn
- 19.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Pt received Kinrix instead of Pediarix. No signs or symptoms noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- N/A
- Andere Medikamente
- D3
- Allergien
- KNA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 0,5
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 27.08.2021
- Beginn
- 27.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
that Kinrix was administered to a 6 month old, instead of Pediarix; Kinrix was administered to a 6 month old; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 6-month-old female patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 27th August 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 27th August 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details provided were as follows: The reporter stated that Kinrix was administered to a 6 month old, instead of Pediarix (should have been 3rd dose) which led to wrong vaccine administered and inappropriate age at vaccination. Reporter consented to follow-up by e-mail.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -